Skip to content

NATRELLE 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants LF-410390Recalls & reported problems

Allergan, Inc. · STYLE 410, LF, 390G BIOCELL |textured|contour|silicone · Class 3 · Implant

All models of Natrelle Breast Implants (1167)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
1

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10888628003125), received between Aug 27, 2021 and Aug 22, 2023 — classified as 3 injuries.

The most frequently reported specific device problem is “Device Appears to Trigger Rejection” (3 reports).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Jul 24, 2019Class IOpen, Classified

    The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma (BIA-ALCL) in patients who have textured breast implants.

    Z-2452-2019 · Root cause: Unknown/Undetermined by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Device Appears to Trigger Rejection3

Patient problems

  • Capsular Contracture3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 22, 2023Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    PLAINTIFF REPORTED LEFT SIDE ONE OR MORE BIOCELL® DEVICES CAUSED PERSONAL INJURIES AND DAMAGES INCLUDING BUT NOT LIMITED TO THE FOLLOWING: REMOVAL OF IMPLANTS DUE TO FEAR ALCL, TO REDUCE RISK OF ALCL, AND DUE TO SYMPTOMS CONSISTENT WITH ALCL AND FEAR OF ALCL INCLUDING: MENTAL ANGUISH AND FEAR OF ALCL, INCREASED RISK OF ALCL, CELLULAR CHANGES AND DAMAGE OF BREAST TISSUE, INFLAMMATION, EVALUATION FOR ALCL, PATHOLOGICAL TESTING OF SURGICAL SPECIMENS, EXPLANT, CAPSULECTOMY, CONTRACTURE, DISCOMFORT, TIGHTNESS, ASYMMETRY, RECONSTRUCTION AND RE-IMPLANTATION, PAIN, ITCHING, SCARRING; AGGRAVATION OF UNDERLYING CONDITIONS; AND OTHER PHYSICAL AND EMOTIONAL MANIFESTATIONS THAT ARE SEVERE AND ONGOING. PLAINTIFF HAS NOT BEEN DIAGNOSED WITH BIA-ALCL. DEVICE WAS EXPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 17599692 ↗
  • InjuryAug 21, 2023Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    DEVICE HAS BEEN EXPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 17585408 ↗
  • InjuryAug 27, 2021Device Appears to Trigger Rejection; Device Appears to Trigger Rejection

    THE DEVICE HAS BEEN EXPLANTED.

    Patient problems: Capsular Contracture

    MAUDE report 12375897 ↗

Other Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices

All Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page